Hodgkin Lymphoma News

• Patient With Blood Cancer Takes on Bias and 'Gaslighting' After having her concerns dismissed by her doctor, a woman diagnosed with Hodgkin lymphoma partnered with the Lymphoma Research Foundation to spread the word about unique challenges facing patients.
  MDedge News, June 01, 2023
• ESMO Breast Cancer 2023 Patritumab Deruxtecan Shows Promise for Breast Cancer A single dose of patritumab deruxtecan provoked a response in nearly one third of patients with HR-positive/HER2-negative or triple-negative breast cancer.
  MDedge News, May 18, 2023
• ESMO Breast Cancer 2023 T-DXd for HER2-Low BC: Analysis Confirms Adverse Effects A safety analysis following a randomized phase 3 trial confirms that vomiting and nausea are common in patients who take the drug trastuzumab deruxtecan to treat HER2-low metastatic breast cancer.
  MDedge News, May 15, 2023
• Repeated CTs in Childhood Linked With Increased Cancer Risk The findings of a recent study emphasize the importance of avoiding unnecessary imaging in children, according to the investigators.
  Medscape Medical News, April 26, 2023
• Healthy Lifestyle Mitigates Impact of Childhood Cancer Survivors of childhood cancer who follow a healthy lifestyle may substantially reduce excess risk of later mortality from causes such as cancer and cardiovascular disease, suggests a new analysis.
  Medscape Medical News, April 10, 2023
• Pfizer in Talks to Buy Cancer Drugmaker Seagen Pfizer is in early stage talks to acquire cancer drugmaker Seagen in a potential multi-billion dollar deal after advanced discussions between Merck and Seagen fell through last year.
  Reuters Health Information, February 27, 2023
• Could Your Patients Benefit? New Trials in Lung Cancer Several studies in lung cancer have started enrolling recently – maybe one of your patients could benefit.
  Medscape Medical News, February 21, 2023
• New Trials in Urologic Cancers: Could Your Patient Benefit? Perhaps one of your patients could benefit from clinical trials that are currently recruiting patients with urologic cancers, including prostate cancer.
  Medscape Medical News, February 06, 2023
• Loneliness Risk Elevated Among Young Cancer Survivors The new analysis found that young adult cancer survivors also face an increased risk for depression, anxiety, and other health problems related to loneliness.
  Medscape Medical News, January 31, 2023
• Cardioprotection for 20 Years for Children With Cancer A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
  Medscape Medical News, January 31, 2023
• Novel HER2 Assay to Predict HER2+ Breast Cancer Tx Response An award-winning genomic assay for measuring HER2 mRNA expression could help predict treatment responses in advanced HER2+ breast cancer and ultimately guide clinical decision-making, suggests study.
  Medscape Medical News, January 25, 2023
• Immune-Related Biomarkers Can Help Guide HER2+ Breast Cancer Tx Immune-related gene expression signatures can predict pathologic complete response and could be used to help decide which HER2 therapies to use for which patients, say researchers.
  Medscape Medical News, January 24, 2023
• New Trials in Leukemia and Lymphoma: Could Your Patient Benefit? Could one of your patients benefit from the latest clinical trials enrolling patients with leukemia or lymphoma?
  Medscape Medical News, January 09, 2023
• SABCS 2022 HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact? One of the problems with the new subgroup of HER2 low tumors is that using current assays to measure low levels "is like weighing mice on a scale built for elephants," says one expert.
  Medscape Medical News, January 05, 2023
• SABCS 2022 T-DXd: 'Remarkable' Survival Gains in Advanced Breast Cancer The antibody-drug conjugate trastuzumab deruxtecan continues to show impressive progression-free and overall survival gains in previously treated unresectable and/or metastatic HER2+ breast cancer.
  Medscape Medical News, December 14, 2022
• ASH 2022 Steep Price for Surviving Childhood Lymphoma: Epigenetic Aging Adult survivors of pediatric Hodgkin lymphoma have accelerated epigenetic aging, and many have evidence of neurocognitive decline on standardized testing.
  Medscape Medical News, December 13, 2022
• SABCS 2022 High Response Rates With T-DXd in Early HER2-Low Breast Cancer "The study provides a rich platform for additional translational research to evaluate more sensitive methods of HER2 detection."
  MDedge News, December 13, 2022
• ASH 2022 ASH 2022: New Clinical Data Challenge Long-held Assumptions Abstracts will include both practice-changing trial results and data showing that sometimes doing less can be better for both for patients and for clinical practice.
  Medscape Medical News, December 05, 2022
• Alert Blenrep for Multiple Myeloma Withdrawn From US Market The manufacturer is pulling the drug from the market at the request of the FDA following disappointing results from a large phase 3 confirmatory trial.
  News Alerts, November 22, 2022
• Brentuximab in Pediatric HL: 'Paradigm Shift' and Just Approved Adding brentuximab vedotin to chemotherapy in pediatric Hodgkin lymphoma produced results that have been hailed as a 'paradigm shift' and have just led to FDA approval for this new indication.
  Medscape Medical News, November 11, 2022